2018 Synaptic vesicle 2 receptors as a novel targets for neuroendocrine cancer therapy

OBJECTIVES/SPECIFIC AIMS: (1) To delineate the function of the heavy-chain receptor binding domain (HCR), a portion of botulinum neurotoxin type A (BoNT/A) and synaptic vesicle 2 (SV2) signaling pathway, which provide a novel multipurpose biologic with potential clinical applications in tumor detect...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Transl Sci
Main Authors: Jaskula-Sztul, Renata, Whitt, Jason D., Ou, Jianfa, Liu, Margaret X., Aburjania, Zviadi, Chen, Herbert
Formato: Artigo
Idioma:Inglês
Publicado: Cambridge University Press 2018
Assuntos:
Basic/Translational Science/Team Science
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6799207/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/cts.2018.125
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares